Observations reveal cDCs enhance anti-tumor activity with RAS(ON) inhibition in pancreatic cancer models, suggesting therapeutic potential.
Supplementary Figure S8: Conventional dendritic cells (cDCs) contribute to the anti-tumor activity of RAS(ON) multi-selective inhibition
No takes yet. Share an insight, caveat, or question.
Orlen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: